Nanjing Hicin Pharmaceutical Co., Ltd.
SHZ: 300584.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yuping Cao
- Employees
- 553
- Headquarters
- Nanjing, China
- IPO year
- 2017
- Market cap
- CN¥5.1B
- Website
- https://www.hicin.cn
Loading 300584…
Loading profile data…Frequently asked questions about 300584
What does Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ) do?
Nanjing Hicin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, marketing, and sale of pharmaceutical preparations and synthetic chemicals in China. The company offers antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for cardio-cerebral system, and immuno-modulate agents. It also...
Where does 300584.SZ trade?
Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300584.SZ in?
Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Nanjing Hicin Pharmaceutical Co., Ltd.?
Yuping Cao is the chief executive officer of Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ).
Where is Nanjing Hicin Pharmaceutical Co., Ltd. headquartered?
Nanjing Hicin Pharmaceutical Co., Ltd. is headquartered in China.
Does 300584.SZ pay a dividend?
Yes — Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ) paid a trailing twelve-month dividend of CNY 0.10 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300584.SZ go public?
Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ) completed its initial public offering in 2017.